BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 09/07/2026

FDA Clears Zolpidem Tartrate Orally Disintegrating Tablets for Approval

The FDA has determined that the 5mg and 10mg versions of TOVALT ODT (zolpidem tartrate) orally disintegrating tablets were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.

Source: Federal Register — Health and Human ServicesOpen original release →